Esomeprazole and omeprazole may possibly boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) leading to improved adverse effects including drowsiness, although the scientific relevance is minimal for most clients – keep track of the affected person for adverse effects (e.If patient can not resume their common oral medicatio